In addition, dichloroacetate, a pyruvate dehydrogenase kinase 1 inhibitor, together with radiotherapy can effectively sensitize glioblastoma cells by inducing the cell-cycle arrest at the G2/M phase [28]. Here, PDK1 is linked to glioblastoma.